Expert Opinion on Pharmacotherapy, Volume 15, Issue 11 (2014)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 15, Issue 11 (2014)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Volume 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Original Research

Article
In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells
Alaaeldin Shablak, David E Gilham, Robert E Hawkins & Eyad Elkord
Pages: 1489-1499
Published online: 03 Jun 2014
AbstractforIn vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells | Full Text | References | PDF (789 KB)
  • 355 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study
Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, Nahoko Takahashi, Yutaka Susuta & Hideki Kuki
Pages: 1501-1515
Published online: 10 Jul 2014
AbstractforEfficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study | Full Text | References | PDF (706.8 KB)
  • 1639 Views
  • 106 CrossRef citations
  • 0Altmetric

Reviews

Review Article
An update on current pharmacotherapy options in atopic dermatitis
Sakari Reitamo MD PhD & Anita Remitz MD PhD
Pages: 1517-1524
Published online: 08 May 2014
AbstractforAn update on current pharmacotherapy options in atopic dermatitis | Full Text | References | PDF (218.4 KB)
  • 752 Views
  • 4 CrossRef citations
  • 0Altmetric
Review Article
Dronabinol and chronic pain: importance of mechanistic considerations
Marjan de Vries MSc, Dagmar CM van Rijckevorsel MSc, Oliver HG Wilder-Smith MD PhD DSc & Harry van Goor MD PhD
Pages: 1525-1534
Published online: 12 May 2014
AbstractforDronabinol and chronic pain: importance of mechanistic considerations | Full Text | References | PDF (267.5 KB)
  • 831 Views
  • 25 CrossRef citations
  • 0Altmetric
Review Article
New formulations of bupivacaine for the treatment of postoperative pain: liposomal bupivacaine and SABER-Bupivacaine
Aaron Skolnik BS & Tong J Gan MD MHS FRCA
Pages: 1535-1542
Published online: 03 Jul 2014
AbstractforNew formulations of bupivacaine for the treatment of postoperative pain: liposomal bupivacaine and SABER-Bupivacaine | Full Text | References | PDF (581.8 KB)
  • 1092 Views
  • 33 CrossRef citations
  • 0Altmetric
Review Article
Pharmacotherapy of focal epilepsy
Anand Iyer & Anthony Marson
Pages: 1543-1551
Published online: 26 May 2014
AbstractforPharmacotherapy of focal epilepsy | Full Text | References | PDF (325.3 KB)
  • 520 Views
  • 13 CrossRef citations
  • 0Altmetric
Review Article
Treating psychosis in movement disorder patients: a review
Leora L Borek MD & Joseph H Friedman MD
Pages: 1553-1564
Published online: 20 May 2014
AbstractforTreating psychosis in movement disorder patients: a review | Full Text | References | PDF (281.3 KB)
  • 812 Views
  • 18 CrossRef citations
  • 0Altmetric
Review Article
Ulcerative proctitis: an update on the pharmacotherapy and management
Krisztina B Gecse MD PhD & Peter L Lakatos MD PhD
Pages: 1565-1573
Published online: 16 May 2014
AbstractforUlcerative proctitis: an update on the pharmacotherapy and management | Full Text | References | PDF (308.4 KB)
  • 642 Views
  • 18 CrossRef citations
  • 0Altmetric
Review Article
Glucocorticoid treatment in rheumatoid arthritis
Rolf Rau
Pages: 1575-1583
Published online: 26 May 2014
AbstractforGlucocorticoid treatment in rheumatoid arthritis | Full Text | References | PDF (244.5 KB)
  • 723 Views
  • 26 CrossRef citations
  • 0Altmetric

Drug Evaluations

Oral vinorelbine in the treatment of non-small-cell lung cancer
Giulia Barletta, Carlo Genova, Erika Rijavec, Giovanni Burrafato, Federica Biello, Claudio Sini, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Irene Vanni, Angela Alama, Sabrina Beltramini, Maria Attilia Grassi, Francesco Boccardo & Francesco Grossi
Pages: 1585-1599
Published online: 27 Jun 2014
AbstractforOral vinorelbine in the treatment of non-small-cell lung cancer | Full Text | References | PDF (316.9 KB)
  • 478 Views
  • 19 CrossRef citations
  • 0Altmetric
Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
Daniel F Connor MD, Amy FT Arnsten PhD, Geraldine S Pearson PhD APRN PMH-CNS FAAN & Gabriella F Greco DO
Pages: 1601-1610
Published online: 03 Jul 2014
AbstractforGuanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents | Full Text | References | PDF (398.5 KB)
  • 715 Views
  • 13 CrossRef citations
  • 0Altmetric
Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes
Shashank R Joshi DM, Ambady Ramachandran MD PhD DSc FRCP FRCP MNAMS FICP, Manoj Chadha DM, Sudip Chatterjee MD MNAMS FRCP FACP, Rahul Rathod MD & Sanjay Kalra DM
Pages: 1611-1620
Published online: 25 Jun 2014
AbstractforAcarbose plus metformin fixed-dose combination in the management of type 2 diabetes | Full Text | References | PDF (802.1 KB)
  • 529 Views
  • 14 CrossRef citations
  • 0Altmetric
Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy
Massimo Breccia MD, Matteo Molica, Irene Zacheo & Giuliana Alimena
Pages: 1621-1630
Published online: 03 Jul 2014
AbstractforAzacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy | Full Text | References | PDF (288 KB)
  • 480 Views
  • 3 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Dapagliflozin – do we need it registered for type 2 diabetes?
Evaluation of Jabbour SA, Hardy E, Sugg J, Parikh S. Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomised, double-blind, placebo-controlled study. Diabetes Care 2014;37:740-50
Sheila A Doggrell PhD DSc & Rinku Tuli PhD
Pages: 1631-1635
Published online: 05 Jul 2014
AbstractforDapagliflozin – do we need it registered for type 2 diabetes? | Full Text | References | PDF (159 KB)
  • 417 Views
  • 1 CrossRef citations
  • 0Altmetric

Appendix

Correction
Erratum
Page: 1637
Published online: 03 Jul 2014
CitationforErratum | Full Text | PDF (44.1 KB)
  • 318 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Related Article

Article
Related articles
Pages: i-ii
Published online: 10 Jul 2014
CitationforRelated articles | Full Text | PDF (92.7 KB)
  • 86 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
View all latest articles